Scarica l'app Stockscreener
9.56
1.16%
0.11
Dopo l'orario di chiusura:
9.56
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché FOLD Giù?
Forum
Previsione
Precedente Chiudi:
$9.45
Aprire:
$9.42
Volume 24 ore:
3.68M
Relative Volume:
0.76
Capitalizzazione di mercato:
$2.95B
Reddito:
$571.16M
Utile/perdita netta:
$-38.10M
Rapporto P/E:
-78.04
EPS:
-0.1225
Flusso di cassa netto:
$-48.91M
1 W Prestazione:
+0.84%
1M Prestazione:
+12.87%
6M Prestazione:
+50.79%
1 anno Prestazione:
+0.63%
Intervallo 1D:
$9.31
$9.615
Intervallo di 1 settimana:
$9.27
$9.88
Portata 52W:
$5.51
$10.36
Amicus Therapeutics Inc Stock (FOLD) Company Profile
Nome
Amicus Therapeutics Inc
Settore
Industria
Telefono
(609) 662-2000
Indirizzo
47 HULFISH STREET, PRINCETON, NJ
Confronta FOLD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FOLD
Amicus Therapeutics Inc
|
9.56 | 2.92B | 571.16M | -38.10M | -48.91M | -0.1225 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Amicus Therapeutics Inc Stock (FOLD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-18 | Aggiornamento | Needham | Hold → Buy |
| 2025-07-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-13 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-09-06 | Iniziato | Jefferies | Buy |
| 2024-05-30 | Iniziato | Wells Fargo | Overweight |
| 2024-05-14 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-12-19 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Ripresa | Goldman | Neutral |
| 2022-01-14 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2021-11-15 | Aggiornamento | Stifel | Hold → Buy |
| 2021-09-30 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-07-19 | Ripresa | BTIG Research | Buy |
| 2021-05-27 | Iniziato | Needham | Hold |
| 2021-05-21 | Iniziato | UBS | Buy |
| 2021-04-14 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-03-02 | Iniziato | Stifel | Hold |
| 2021-02-12 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-12-28 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-12-10 | Downgrade | Citigroup | Buy → Neutral |
| 2020-11-11 | Iniziato | Berenberg | Hold |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2020-02-04 | Ripresa | Cantor Fitzgerald | Overweight |
| 2019-11-12 | Reiterato | H.C. Wainwright | Buy |
| 2019-06-17 | Iniziato | H.C. Wainwright | Buy |
| 2019-06-05 | Reiterato | Cantor Fitzgerald | Overweight |
| 2019-04-05 | Iniziato | Janney | Buy |
| 2019-01-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-10-29 | Iniziato | Citigroup | Neutral |
| 2018-08-17 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2017-10-06 | Ripresa | Goldman | Neutral |
| 2017-09-13 | Reiterato | Chardan Capital Markets | Buy |
| 2017-08-10 | Reiterato | Chardan Capital Markets | Buy |
| 2017-01-24 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2016-05-18 | Iniziato | BofA/Merrill | Buy |
| 2016-04-14 | Iniziato | Robert W. Baird | Neutral |
| 2016-04-12 | Reiterato | Chardan Capital Markets | Buy |
| 2015-09-16 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2015-06-16 | Reiterato | Chardan Capital Markets | Buy |
Mostra tutto
Amicus Therapeutics Inc Borsa (FOLD) Ultime notizie
Primecap Management Co. CA Sells 123,400 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
First Week of July 2026 Options Trading For Amicus Therapeutics (FOLD) - Nasdaq
Is Amicus Therapeutics Inc. stock supported by strong fundamentalsAnalyst Upgrade & Daily Stock Trend Reports - newser.com
Vise Technologies Inc. Takes Position in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Is Amicus Therapeutics Inc. stock attractive for growth ETFs2025 Price Momentum & Fast Momentum Entry Tips - newser.com
What insider trading reveals about Amicus Therapeutics Inc. stockTrade Entry Summary & Weekly High Momentum Picks - newser.com
Is Amicus Therapeutics Inc. stock attractive for ETFsInflation Watch & AI Forecasted Stock Moves - newser.com
Published on: 2025-11-20 05:57:54 - newser.com
What RSI levels show for Amicus Therapeutics Inc. (AM6) stockQuarterly Investment Review & Free Expert Approved Momentum Trade Ideas - newser.com
Is Amicus Therapeutics Inc. (AM6) stock vulnerable to rate hikesJuly 2025 Price Swings & Accurate Buy Signal Alerts - newser.com
Institutional scanner results for Amicus Therapeutics Inc.2025 Key Lessons & Weekly Breakout Stock Alerts - newser.com
Is Amicus Therapeutics Inc. trending in predictive chart modelsMarket Activity Recap & Free Fast Gain Swing Trade Alerts - newser.com
Is Amicus Therapeutics Inc. stock in correction or buying zone - newser.com
Why Amicus Therapeutics Inc. stock is a must watch in 20252025 Biggest Moves & Free Safe Capital Growth Stock Tips - newser.com
Is Amicus Therapeutics Inc. meeting your algorithmic filter criteria2025 Technical Patterns & Long-Term Safe Investment Plans - newser.com
Can Amicus Therapeutics Inc. stock maintain growth trajectoryMarket Performance Summary & Growth Focused Entry Reports - newser.com
Does Amicus Therapeutics Inc. stock trade at a discount to peers - newser.com
How forex fluctuations impact Amicus Therapeutics Inc. (AM6) stock2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - newser.com
Is Amicus Therapeutics Inc. (AM6) stock good for long term investingShare Buyback & AI Enhanced Market Trend Forecasts - newser.com
Understanding Amicus Therapeutics Inc.’s price movement - newser.com
Is Amicus Therapeutics Inc. (AM6) stock nearing a technical breakoutJuly 2025 Retail & Free High Return Stock Watch Alerts - newser.com
Why Amicus Therapeutics Inc. (AM6) stock is trending on social media2025 Bull vs Bear & Growth-Oriented Investment Plans - newser.com
Published on: 2025-11-18 18:34:31 - newser.com
Published on: 2025-11-18 15:37:13 - newser.com
Amicus Therapeutics Shifts To Profit As Rare Disease Sales Climb - Finimize
How to manage a losing position in Amicus Therapeutics Inc.Weekly Trade Summary & Detailed Earnings Play Strategies - newser.com
Amicus Therapeutics Inc Azioni (FOLD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):